Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes

Overview of attention for article published in Nature Communications, November 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog
twitter: 21 X users

wikipedia: 1 Wikipedia page
reddit: 1 Redditor
bluesky: 1 Bluesky user

Readers on

mendeley: 348 Mendeley

So far, Altmetric has seen 27 X posts from 21 X users, with an upper bound of 425,844 followers.

RT @SusanGKomen: She co-led a study with former Komen Grantee Brian Lehmann, Ph.D., that found a subtype of TNBC that can escape detection…

She co-led a study with former Komen Grantee Brian Lehmann, Ph.D., that found a subtype of TNBC that can escape detection by the immune system and evade immunotherapy. https://t.co/hTYOmGOP62 https://t.co/dxsUMT52NW

(#TNBC) is a collection of biologically diverse cancers characterized by distinct transcriptional patterns, biology, and immune composition. TNBCs subtypes include two basal-like (BL1, BL2), a mesenchymal (M) and a luminal androgen receptor (LAR) subtyp…

*Research Asst. Professor Hanbig An worked on a project that describes the genomic landscape of triple-negative breast cancer subtypes. Findings from the study suggest additional treatment strategies for TNBC. @acolaprico @DrJKingJames @paulagericsson …

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 23 additional X posts.